Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (55 ops.)
Latest filing published 17 Sept 2026 for Travere Therapeutics, Inc., €617k.
Filing timeline
BuySaleWilliam E. Rote
Insider track record
Disclosed buys
0
Disclosed sells
55
Signal history
William E. Rote: trading record in brief
William E. Rote (chief executive) discloses dealings in Travere Therapeutics, Inc. to SEC (Form 4). Between 13 February 2017 and 16 September 2026, the trades on record add up to 85 filings.
On the market, this insider has only sold: 55 sales, €13.3M in total. Besides market trades, the filings include 22 share grants and 8 option exercises. In 2026 alone, the filings show no purchases and 7 sales.
The record was last updated on 17 September 2026 with an option exercise (€617k) in Travere Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to William E. Rote
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations85 total
39,650 shares@ US$17.960.015% mcap3.7% of flowCommon StockSEC:0001698262-26-000005:1
29,021 shares@ US$62.65520.038% mcap9.6% of flowCommon StockSEC:0001698262-26-000005:3
3,000 shares@ US$63.65080.0040% mcap1.0% of flowCommon StockSEC:0001698262-26-000005:4
65,104 shares@ US$63.12050.087% mcap21.6% of flowCommon StockSEC:0001698262-26-000005:9
55,000 shares@ US$15.460.018% mcap4.5% of flowCommon StockSEC:0001698262-26-000005:7
39,000 shares@ US$25.250.021% mcap5.2% of flowCommon StockSEC:0001698262-26-000005:0
63,907 shares@ US$61.9940.083% mcap20.8% of flowCommon StockSEC:0001698262-26-000005:2
270 shares@ US$65.310.0004% mcap0.1% of flowCommon StockSEC:0001698262-26-000005:5
350 shares@ US$17.960.0001% mcap0.0% of flowCommon StockSEC:0001698262-26-000005:6
57,500 shares@ US$26.880.033% mcap8.1% of flowCommon StockSEC:0001698262-26-000005:8
47,746 shares@ US$63.61260.064% mcap16.0% of flowCommon StockSEC:0001698262-26-000005:10
9,100 shares@ US$39.090.0064% mcap1.8% of flowCommon StockSEC:0001698262-26-000003:0
14,000 shares0Common StockSEC:0001698262-26-000002:0
20,090 shares0Common StockSEC:0001698262-26-000001:0
60,000 shares@ US$20.616.4% of flowCommon StockSEC:0001698262-25-000005:0
4,920 sharesCommon StockSEC:0001415889-25-012056:0
5,200 shares@ US$23.53Common StockSEC:0001415889-25-003824:1
8,000 sharesCommon StockSEC:0001415889-25-003824:0
8,951 shares@ US$19.78Common StockSEC:0001415889-25-003067:1
21,500 shares0Common StockSEC:0001415889-25-003067:0
2,437 shares@ US$19.460.3% of flowCommon StockSEC:0001415889-25-002008:0
4,387 shares@ US$11.52Common StockSEC:0001415889-24-023096:1
6,750 shares0Common StockSEC:0001415889-24-023096:0
2,174 shares@ US$8.53Common StockSEC:0001415889-24-002284:1
2,590 shares@ US$8.86Common StockSEC:0001415889-24-002284:2
25 of 85 declarations
